• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿尔茨海默病中的小胶质细胞。

Microglia in Alzheimer's disease.

机构信息

Department of Neuroscience, Genentech, Inc., South San Francisco, CA

Department of Neuroscience, Genentech, Inc., South San Francisco, CA.

出版信息

J Cell Biol. 2018 Feb 5;217(2):459-472. doi: 10.1083/jcb.201709069. Epub 2017 Dec 1.

DOI:10.1083/jcb.201709069
PMID:29196460
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5800817/
Abstract

Proliferation and activation of microglia in the brain, concentrated around amyloid plaques, is a prominent feature of Alzheimer's disease (AD). Human genetics data point to a key role for microglia in the pathogenesis of AD. The majority of risk genes for AD are highly expressed (and many are selectively expressed) by microglia in the brain. There is mounting evidence that microglia protect against the incidence of AD, as impaired microglial activities and altered microglial responses to β-amyloid are associated with increased AD risk. On the other hand, there is also abundant evidence that activated microglia can be harmful to neurons. Microglia can mediate synapse loss by engulfment of synapses, likely via a complement-dependent mechanism; they can also exacerbate tau pathology and secrete inflammatory factors that can injure neurons directly or via activation of neurotoxic astrocytes. Gene expression profiles indicate multiple states of microglial activation in neurodegenerative disease settings, which might explain the disparate roles of microglia in the development and progression of AD pathology.

摘要

大脑中微胶质细胞的增殖和激活,集中在淀粉样斑块周围,是阿尔茨海默病(AD)的一个显著特征。人类遗传学数据表明,微胶质细胞在 AD 的发病机制中起着关键作用。大多数 AD 的风险基因在大脑中的微胶质细胞中高度表达(许多是选择性表达)。越来越多的证据表明,微胶质细胞可以预防 AD 的发生,因为微胶质细胞的活动受损和对β-淀粉样蛋白的反应改变与 AD 风险的增加有关。另一方面,也有大量证据表明,激活的微胶质细胞可能对神经元有害。微胶质细胞可以通过吞噬突触来介导突触的丧失,可能通过补体依赖性机制;它们还可以加剧 tau 病理学,并分泌炎症因子,直接或通过激活神经毒性星形胶质细胞来损伤神经元。基因表达谱表明,在神经退行性疾病的情况下,微胶质细胞存在多种激活状态,这可能解释了微胶质细胞在 AD 病理发展和进展中的不同作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15d7/5800817/fe8eb9fb06fa/JCB_201709069_Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15d7/5800817/df9e6004a3d4/JCB_201709069_Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15d7/5800817/c364e214519d/JCB_201709069_Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15d7/5800817/fe8eb9fb06fa/JCB_201709069_Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15d7/5800817/df9e6004a3d4/JCB_201709069_Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15d7/5800817/c364e214519d/JCB_201709069_Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15d7/5800817/fe8eb9fb06fa/JCB_201709069_Fig3.jpg

相似文献

1
Microglia in Alzheimer's disease.阿尔茨海默病中的小胶质细胞。
J Cell Biol. 2018 Feb 5;217(2):459-472. doi: 10.1083/jcb.201709069. Epub 2017 Dec 1.
2
Diabetic phenotype in mouse and humans reduces the number of microglia around β-amyloid plaques.在小鼠和人类中,糖尿病表型减少了β-淀粉样斑块周围的小胶质细胞数量。
Mol Neurodegener. 2020 Nov 10;15(1):66. doi: 10.1186/s13024-020-00415-2.
3
Glial cells in Alzheimer's disease: From neuropathological changes to therapeutic implications.阿尔茨海默病中的神经胶质细胞:从神经病理学改变到治疗意义
Ageing Res Rev. 2022 Jun;78:101622. doi: 10.1016/j.arr.2022.101622. Epub 2022 Apr 12.
4
Identification and therapeutic modulation of a pro-inflammatory subset of disease-associated-microglia in Alzheimer's disease.鉴定和治疗阿尔茨海默病中与疾病相关的小胶质细胞的促炎亚群。
Mol Neurodegener. 2018 May 21;13(1):24. doi: 10.1186/s13024-018-0254-8.
5
GFAP and vimentin deficiency alters gene expression in astrocytes and microglia in wild-type mice and changes the transcriptional response of reactive glia in mouse model for Alzheimer's disease.胶质纤维酸性蛋白(GFAP)和波形蛋白缺乏会改变野生型小鼠星形胶质细胞和小胶质细胞中的基因表达,并改变阿尔茨海默病小鼠模型中反应性胶质细胞的转录反应。
Glia. 2015 Jun;63(6):1036-56. doi: 10.1002/glia.22800. Epub 2015 Mar 2.
6
Microglia as a potential bridge between the amyloid beta-peptide and tau.小胶质细胞作为淀粉样β肽和tau蛋白之间的潜在桥梁。
Ann N Y Acad Sci. 2004 Dec;1035:85-103. doi: 10.1196/annals.1332.006.
7
CSF1R inhibition rescues tau pathology and neurodegeneration in an A/T/N model with combined AD pathologies, while preserving plaque associated microglia.CSF1R 抑制可挽救具有 AD 相关病理的 A/T/N 模型中的 Tau 病理和神经退行性变,同时保留斑块相关的小胶质细胞。
Acta Neuropathol Commun. 2021 Jun 8;9(1):108. doi: 10.1186/s40478-021-01204-8.
8
Microglia, neuroinflammation, and beta-amyloid protein in Alzheimer's disease.阿尔茨海默病中的小胶质细胞、神经炎症和β-淀粉样蛋白
Int J Neurosci. 2014 May;124(5):307-21. doi: 10.3109/00207454.2013.833510. Epub 2013 Sep 12.
9
Eliminating microglia in Alzheimer's mice prevents neuronal loss without modulating amyloid-β pathology.在阿尔茨海默病小鼠中清除小胶质细胞可预防神经元丢失,而不调节淀粉样β蛋白病变。
Brain. 2016 Apr;139(Pt 4):1265-81. doi: 10.1093/brain/aww016. Epub 2016 Feb 26.
10
Manipulation of microglial activity as a therapy for Alzheimer's disease.调节小胶质细胞活性作为治疗阿尔茨海默病的一种方法。
Front Biosci (Schol Ed). 2012 Jun 1;4(4):1402-12. doi: 10.2741/s342.

引用本文的文献

1
Down syndrome and a presenilin 2 variant: dual genetic risk of Alzheimer's disease.唐氏综合征与早老素2变异体:阿尔茨海默病的双重遗传风险
Acta Neuropathol. 2025 Sep 4;150(1):24. doi: 10.1007/s00401-025-02931-1.
2
Noradrenergic therapies in neurodegenerative disease: from symptomatic to disease modifying therapy?神经退行性疾病中的去甲肾上腺素能疗法:从对症治疗到疾病修饰治疗?
Brain Commun. 2025 Aug 25;7(5):fcaf310. doi: 10.1093/braincomms/fcaf310. eCollection 2025.
3
The Janus face of CaMKII: from memory consolidation to neurotoxic switch in Alzheimer's disease.

本文引用的文献

1
Diverse Brain Myeloid Expression Profiles Reveal Distinct Microglial Activation States and Aspects of Alzheimer's Disease Not Evident in Mouse Models.多样化的大脑髓系表达谱揭示了不同的小胶质细胞激活状态和阿尔茨海默病的方面,这些在小鼠模型中并不明显。
Cell Rep. 2018 Jan 16;22(3):832-847. doi: 10.1016/j.celrep.2017.12.066.
2
TREM2 deficiency attenuates neuroinflammation and protects against neurodegeneration in a mouse model of tauopathy.TREM2 缺乏可减轻神经炎症并预防神经退行性变tau 病模型中的小鼠。
Proc Natl Acad Sci U S A. 2017 Oct 24;114(43):11524-11529. doi: 10.1073/pnas.1710311114. Epub 2017 Oct 9.
3
TREM2 deficiency exacerbates tau pathology through dysregulated kinase signaling in a mouse model of tauopathy.
钙调蛋白激酶II的双面性:从记忆巩固到阿尔茨海默病中的神经毒性转变
Arch Toxicol. 2025 Sep 1. doi: 10.1007/s00204-025-04160-7.
4
Emerging Role of Oligodendrocytes Malfunction in the Progression of Alzheimer's Disease.少突胶质细胞功能障碍在阿尔茨海默病进展中的新作用。
J Neuroimmune Pharmacol. 2025 Sep 1;20(1):79. doi: 10.1007/s11481-025-10236-z.
5
Paclitaxel-induced adverse effects: insights into multi-organ toxicities and molecular mechanisms.紫杉醇诱导的不良反应:对多器官毒性及分子机制的见解
Naunyn Schmiedebergs Arch Pharmacol. 2025 Aug 27. doi: 10.1007/s00210-025-04480-6.
6
Ceria-nanocluster based therapy for Alzheimer's disease through the modulation of activated microglia and attenuation of amyloid-β deposition.基于二氧化铈纳米团簇的阿尔茨海默病治疗:通过调节活化的小胶质细胞和减轻淀粉样β蛋白沉积
Cell Biomater. 2025 Aug 6. doi: 10.1016/j.celbio.2025.100158.
7
Ms4a4a deficiency ameliorates plaque pathology in a mouse model of amyloid accumulation.Ms4a4a基因缺陷改善了淀粉样蛋白积累小鼠模型中的斑块病理学状况。
Alzheimers Dement. 2025 Aug;21(8):e70580. doi: 10.1002/alz.70580.
8
Salidroside Attenuates Epilepsy and Cognitive Dysfunction in Rats by Downregulating Complement C3-C3aR Pathway-Mediated Activation of Microglia and Astrocytes.红景天苷通过下调补体C3-C3aR途径介导的小胶质细胞和星形胶质细胞激活减轻大鼠癫痫和认知功能障碍。
Neurochem Res. 2025 Aug 21;50(5):271. doi: 10.1007/s11064-025-04514-8.
9
Bridging regional neurovascular unit heterogeneity and cognitive function: a review.弥合区域神经血管单元异质性与认知功能之间的关系:综述
Fluids Barriers CNS. 2025 Aug 20;22(1):85. doi: 10.1186/s12987-025-00697-y.
10
Endothelial delivery of simvastatin by LRP1-targeted nanoparticles ameliorates pathogenesis of alzheimer's disease in a mouse model.通过靶向低密度脂蛋白受体相关蛋白1(LRP1)的纳米颗粒进行辛伐他汀的内皮递送可改善阿尔茨海默病小鼠模型的发病机制。
Alzheimers Res Ther. 2025 Aug 20;17(1):193. doi: 10.1186/s13195-025-01840-5.
TREM2 缺乏通过调节激酶信号通路加剧 tau 病理改变,在 tau 病小鼠模型中。
Mol Neurodegener. 2017 Oct 16;12(1):74. doi: 10.1186/s13024-017-0216-6.
4
ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy.在tau蛋白病小鼠模型中,载脂蛋白E4(ApoE4)显著加剧了tau介导的神经退行性变。
Nature. 2017 Sep 28;549(7673):523-527. doi: 10.1038/nature24016. Epub 2017 Sep 20.
5
The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Microglia in Neurodegenerative Diseases.TREM2-载脂蛋白E通路驱动神经退行性疾病中功能失调的小胶质细胞的转录表型。
Immunity. 2017 Sep 19;47(3):566-581.e9. doi: 10.1016/j.immuni.2017.08.008.
6
A somatic mutation in erythro-myeloid progenitors causes neurodegenerative disease.红系髓系祖细胞中的体细胞突变会引发神经退行性疾病。
Nature. 2017 Sep 21;549(7672):389-393. doi: 10.1038/nature23672. Epub 2017 Aug 30.
7
TREM2 Maintains Microglial Metabolic Fitness in Alzheimer's Disease.触发受体表达于髓细胞2(TREM2)维持阿尔茨海默病中小胶质细胞的代谢适应性。
Cell. 2017 Aug 10;170(4):649-663.e13. doi: 10.1016/j.cell.2017.07.023.
8
TREM2 in Neurodegenerative Diseases.TREM2 在神经退行性疾病中的作用。
Mol Neurodegener. 2017 Aug 2;12(1):56. doi: 10.1186/s13024-017-0197-5.
9
Alzheimer's-Causing Mutations Shift Aβ Length by Destabilizing γ-Secretase-Aβn Interactions.导致阿尔茨海默病的突变通过破坏 γ-分泌酶-Aβn 相互作用来改变 Aβ 的长度。
Cell. 2017 Jul 27;170(3):443-456.e14. doi: 10.1016/j.cell.2017.07.004.
10
Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease.PLCG2、ABI3和TREM2中的罕见编码变异表明小胶质细胞介导的先天性免疫与阿尔茨海默病有关。
Nat Genet. 2017 Sep;49(9):1373-1384. doi: 10.1038/ng.3916. Epub 2017 Jul 17.